Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2013, Article ID 808914, 7 pages
http://dx.doi.org/10.1155/2013/808914
Research Article

Labisia pumila Upregulates Peroxisome Proliferator-Activated Receptor Gamma Expression in Rat Adipose Tissues and 3T3-L1 Adipocytes

1Cardiovascular, Diabetes and Nutrition Research Centre, Institute for Medical Research, 50588 Jalan Pahang, Kuala Lumpur, Malaysia
2Department of Molecular Medicine and Surgery, Karolinska Institute, 171 76 Stockholm, Sweden
3Department of Physiology, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden

Received 25 April 2013; Accepted 18 June 2013

Academic Editor: Neal Davies

Copyright © 2013 Fazliana Mansor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. H. Burkill, Dictionary of the Economic Products of the Malay Peninsula, vol. 2, Crown Agents for the Colonies, London, UK, 1935.
  2. B. Sunarno, “Revision of the genus Labisia (Myrsinaceae),” Blumea, vol. 50, no. 3, pp. 579–597, 2005. View at Google Scholar · View at Scopus
  3. M. Zakaria and M. A. Mohd, Traditional Malay Medicinal Plants, Penerbit Fajar Bakti Sdn Bhd, Kuala Lumpur, Malaysia, 1994.
  4. M. Norhaiza, M. Maziah, and M. Hakiman, “Antioxidative properties of leaf extracts of a popular Malaysian herb, Labisia pumila,” Journal of Medicinal Plant Research, vol. 3, no. 4, pp. 217–223, 2009. View at Google Scholar · View at Scopus
  5. E. Karimi, H. Z. E. Jaafar, and S. Ahmad, “Phytochemical analysis and antimicrobial activities of methanolic extracts of leaf, stem and root from different varieties of labisa pumila benth,” Molecules, vol. 16, no. 6, pp. 4438–4450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Gayet, V. Leray, M. Saito, B. Siliart, and P. Nguyen, “The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-γ target genes, in dogs,” British Journal of Nutrition, vol. 98, no. 3, pp. 497–503, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Fonseca-Alaniz, J. Takada, M. I. C. Alonso-Vale, and F. B. Lima, “Adipose tissue as an endocrine organ: from theory to practice,” Jornal de Pediatria, vol. 83, no. 5, supplement, pp. S192–S203, 2007. View at Google Scholar · View at Scopus
  8. A. Guilherme, J. V. Virbasius, V. Puri, and M. P. Czech, “Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes,” Nature Reviews Molecular Cell Biology, vol. 9, no. 5, pp. 367–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. E. Kahn, R. L. Hull, and K. M. Utzschneider, “Mechanisms linking obesity to insulin resistance and type 2 diabetes,” Nature, vol. 444, no. 7121, pp. 840–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Greene, B. Blumberg, O. W. McBride et al., “isolation of the human peroxisome proliferator activated receptor γ cDNA: expression in hematopoietic cells and chromosomal mapping,” Gene Expression, vol. 4, no. 4-5, pp. 281–299, 1995. View at Google Scholar · View at Scopus
  11. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Rangwala and M. A. Lazar, “Peroxisome proliferator-activated receptor γ in diabetes and metabolism,” Trends in Pharmacological Sciences, vol. 25, no. 6, pp. 331–336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Velebit, P. B. Kovacic, M. Prebil et al., “Rosiglitazone modulates insulin-induced plasma membrane area changes in single 3T3-L1 adipocytes,” Journal of Membrane Biology, vol. 223, no. 3, pp. 141–149, 2008. View at Publisher · View at Google Scholar
  14. T. P. Combs, J. A. Wagner, J. Berger et al., “Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization,” Endocrinology, vol. 143, no. 3, pp. 998–1007, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Maeda, M. Takahashi, T. Funahashi et al., “PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein,” Diabetes, vol. 50, no. 9, pp. 2094–2099, 2001. View at Google Scholar · View at Scopus
  16. J. P. Berger, “Role of PPARγ, transcriptional cofactors, and adiponectin in the regulation of nutrient metabolism, adipogenesis and insulin action: view from the chair,” International Journal of Obesity, vol. 29, no. 1, supplement, pp. S3–S4, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Penumetcha and N. Santanam, “Nutraceuticals as ligands of PPARγ,” PPAR Research, vol. 2012, Article ID 858352, 7 pages, 2012. View at Publisher · View at Google Scholar
  18. D. A. Ehrmann, “Polycystic ovary syndrome,” New England Journal of Medicine, vol. 352, no. 12, pp. 1223–1277, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. H. Balen, G. S. Conway, G. Kaltsas et al., “Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients,” Human Reproduction, vol. 10, no. 8, pp. 2107–2111, 1995. View at Google Scholar · View at Scopus
  20. R. Azziz, “PCOS: a diagnostic challenge,” Reproductive BioMedicine Online, vol. 8, no. 6, pp. 644–648, 2004. View at Google Scholar · View at Scopus
  21. T. M. Barber, M. I. McCarthy, J. A. H. Wass, and S. Franks, “Obesity and polycystic ovary syndrome,” Clinical Endocrinology, vol. 65, no. 2, pp. 137–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. L. Hirschberg, “Polycystic ovary syndrome, obesity and reproductive implications,” Women's Health, vol. 5, no. 5, pp. 529–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Mannerås, M. Fazliana, W. M. Wan Nazaimoon et al., “Beneficial metabolic effects of the Malaysian herb Labisia pumila var. alata in a rat model of polycystic ovary syndrome,” Journal of Ethnopharmacology, vol. 127, no. 2, pp. 346–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Yusoff and W. M. Wan Nazaimoon, “Process for preparation of Labisia pumila extract,” United States Patent US7879368B2, 2011.
  25. L. Mannerås, S. Cajander, A. Holmäng et al., “A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome,” Endocrinology, vol. 148, no. 8, pp. 3781–3791, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Fazliana, W. M. Wan Nazaimoon, H. F. Gu, and C.-G. Östenson, “Labisia pumila extract regulates body weight and adipokines in ovariectomized rats,” Maturitas, vol. 62, no. 1, pp. 91–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. V. P. Knutson and Y. Balba, “3T3-L1 adipocytes as a cell culture model of insulin resistance,” In Vitro Cellular and Developmental Biology, vol. 33, no. 2, pp. 77–81, 1997. View at Google Scholar · View at Scopus
  28. L. Martinez, M. Berenguer, M. C. Bruce, Y. Le Marchand-Brustel, and R. Govers, “Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling,” Biochemical Pharmacology, vol. 79, no. 9, pp. 1300–1309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. K. W. Lee, Y. H. Ku, M. Kim, B. Y. Ahn, S. S. Chung, and K. S. Park, “Effects of sulfonylureas on peroxisome proliferator-activated receptor γ activity and on glucose uptake by thiazolidinediones,” Diabetes & Metabolism Journal, vol. 35, no. 4, pp. 340–347, 2011. View at Google Scholar
  30. L. S. Chua, S. Y. Lee, N. Abdullah, and M. R. Sarmidi, “Review on Labisia pumila (Kacip Fatimah): bioactive phytochemicals and skin collagen synthesis promoting herb,” Fitoterapia, vol. 83, no. 8, pp. 1322–1335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. A. Al-Mekhlafi, K. Shaari, F. Abas et al., “Alkenylresorcinols and cytotoxic activity of the constituents isolated from Labisia pumila,” Phytochemistry, vol. 80, pp. 42–49, 2012. View at Google Scholar
  32. V. Bhatia and P. Viswanathan, “Insulin resistance and PPAR insulin sensitizers,” Current Opinion in Investigational Drugs, vol. 7, no. 10, pp. 891–897, 2006. View at Google Scholar · View at Scopus
  33. S. Mudaliar and R. R. Henry, “New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers,” Annual Review of Medicine, vol. 52, pp. 239–257, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Auwerx, “PPARγ, the ultimate thrifty gene,” Diabetologia, vol. 42, no. 9, pp. 1033–1049, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Olefsky, “Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 467–472, 2000. View at Google Scholar · View at Scopus
  36. J. M. Ntambi and K. Young-Cheul, “Adipocyte differentiation and gene expression,” Journal of Nutrition, vol. 130, no. 12, pp. 3122S–3126S, 2000. View at Google Scholar
  37. M. F. White and C. R. Kahn, “The insulin signaling system,” Journal of Biological Chemistry, vol. 269, no. 1, pp. 1–4, 1994. View at Google Scholar · View at Scopus
  38. F. Giorgino, A. Leonardini, L. Laviola, S. Perrini, and A. Natalicchio, “Cross-talk between PPARγ and insulin signaling and modulation of insulin sensitivity,” PPAR Research, vol. 2009, Article ID 818945, 12 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus